OptimizeRx Corporation (OPRX)
OptimizeRx Statistics
Share Statistics
OptimizeRx has 18.49M shares outstanding. The number of shares has increased by 1.21% in one year.
| Shares Outstanding | 18.49M |
| Shares Change (YoY) | 1.21% |
| Shares Change (QoQ) | 0.38% |
| Owned by Institutions (%) | 62.05% |
| Shares Floating | 16.86M |
| Failed to Deliver (FTD) Shares | 22 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.74M, so 9.43% of the outstanding shares have been sold short.
| Short Interest | 1.74M |
| Short % of Shares Out | 9.43% |
| Short % of Float | 9.84% |
| Short Ratio (days to cover) | 6.47 |
Valuation Ratios
The PE ratio is -4.42 and the forward PE ratio is 15.52. OptimizeRx's PEG ratio is -0.65.
| PE Ratio | -4.42 |
| Forward PE | 15.52 |
| PS Ratio | 0.97 |
| Forward PS | 1.5 |
| PB Ratio | 0.76 |
| P/FCF Ratio | 18.61 |
| PEG Ratio | -0.65 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for OptimizeRx.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.89 |
| Quick Ratio | 2.89 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.27 |
| Debt / FCF | 0.5 |
| Interest Coverage | -2.23 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $719.74K |
| Profits Per Employee | $-157.11K |
| Employee Count | 128 |
| Asset Turnover | 0.54 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 725K |
| Effective Tax Rate | -3.74% |
Stock Price Statistics
The stock price has increased by -12.19% in the last 52 weeks. The beta is 1.18, so OptimizeRx's price volatility has been higher than the market average.
| Beta | 1.18 |
| 52-Week Price Change | -12.19% |
| 50-Day Moving Average | 7.4 |
| 200-Day Moving Average | 6.89 |
| Relative Strength Index (RSI) | 64.77 |
| Average Volume (20 Days) | 521.41K |
Income Statement
In the last 12 months, OptimizeRx had revenue of 92.13M and earned -20.11M in profits. Earnings per share was -1.1.
| Revenue | 92.13M |
| Gross Profit | 59.38M |
| Operating Income | -13.71M |
| Net Income | -20.11M |
| EBITDA | -8.9M |
| EBIT | -13.22M |
| Earnings Per Share (EPS) | -1.1 |
Balance Sheet
The company has 13.38M in cash and 2.38M in debt, giving a net cash position of 11M.
| Cash & Cash Equivalents | 13.38M |
| Total Debt | 2.38M |
| Net Cash | 11M |
| Retained Earnings | -84.37M |
| Total Assets | 171.17M |
| Working Capital | 35.32M |
Cash Flow
In the last 12 months, operating cash flow was 4.89M and capital expenditures -112K, giving a free cash flow of 4.78M.
| Operating Cash Flow | 4.89M |
| Capital Expenditures | -112K |
| Free Cash Flow | 4.78M |
| FCF Per Share | 0.26 |
Margins
Gross margin is 64.45%, with operating and profit margins of -14.88% and -21.83%.
| Gross Margin | 64.45% |
| Operating Margin | -14.88% |
| Pretax Margin | -21.04% |
| Profit Margin | -21.83% |
| EBITDA Margin | -9.66% |
| EBIT Margin | -14.88% |
| FCF Margin | 5.19% |
Dividends & Yields
OPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for OPRX is $8, which is -12.6% lower than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | -12.6% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on May 14, 2018. It was a backward split with a ratio of 1:3.
| Last Split Date | May 14, 2018 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | 1.63 |
| Piotroski F-Score | 5 |